BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited has announced a change in the interests of director Jayne Shaw, with an acquisition of 330,000 ordinary shares, valued at $33,000. The transaction occurred as part of a capital raise approved by shareholders and a reorganization of holdings within the director’s controlled entities. No interests were disposed, and the director’s total holdings in the company have increased significantly.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.